Tag: Dipan Mehta

Tata Steel great stock to have in portfolio; positive on HFCs, says Dipan Mehta

KV Prasad Jun 13, 2022, 06:35 AM IST (Published)

Listen to the Article (6 Minutes)

Dipan Mehta, Director at Elixir Equities, says Tata Steel is a “great stock” to have in the portfolio for the next six-twelve months.

“Try buying it 5-10 percent cheaper or so but otherwise also it is a great stock to have in the portfolio for the next six-twelve months,” said Mehta while talking about Tata Steel in an interview with CNBC-TV18.

According to him, there are many sectors in which unlock trade may play out really well. “It could be realty, it could be housing finance, it could be appliances and even the banks.”

On Bharat Petroleum Corporation Ltd (BPCL), he said, “I would not like to play the BPCL or the privatisation trade or any other oil companies at this point of time and I think there are better opportunities elsewhere than some of these businesses.”

Disclaimer: The views and investment tips expressed by investment experts on CNBCTV18.com are their own and not that of the website or its management. CNBCTV18.com advises users to check with certified experts before taking any investment decisions.

Elon Musk forms several ‘X Holdings’ companies to fund potential Twitter buyout

3 Mins Read

Thursday’s filing dispelled some doubts, though Musk still has work to do. He and his advisers will spend the coming days vetting potential investors for the equity portion of his offer, according to people familiar with the matter

KV Prasad Journo follow politics, process in Parliament and US Congress. Former Congressional APSA-Fulbright Fellow

Banks best way to play recovery theme; buy pharma on dips: Elixir

KV Prasad Jun 13, 2022, 06:35 AM IST (Published)

Listen to the Article (6 Minutes)

Dipan Mehta, Director, Elixir Equities is not bullish on the unlock theme.

“There is certainly going to be change of habits, change of plans as far as consumers are concerned and this trade of unlock may play out for some more time, but over the longer term I am not optimistic on these businesses which rely on crowds coming to their premises,” Mehta told CNBC-TV18.

According to Mehta, banks are the best way to play the opening up of the economy.

“Banks have done exceedingly well and fears around the NPAs are receding and the concerns are now around credit growth which has been pretty weak for various reasons within the banking sector and now economy opening up certainly there is more opportunity to increase the lending portfolio and valuations are quite reasonable over there, so the best way to play this unlock theme is through the banks, and there are many choices over there as far as banks are concerned.”

On pharma Mehta said, “If you are underweight and even at this point of time you should look at adding weightage to pharma companies. Numbers from Cipla, and Dr. Reddy’s Laboratories were exceptionally good as of Divi’s Laboratories and these companies are becoming like a must own in the portfolio and clearly I think over the next 2-3 years or so we could see very good returns coming from the top pharma companies. So I am very positive on pharma and correction are good opportunities to increase exposure but one should maintain a fair balance as far as pharma is concerned.”

Disclaimer: The views and investment tips expressed by investment experts on CNBCTV18.com are their own and not that of the website or its management. CNBCTV18.com advises users to check with certified experts before taking any investment decisions.

Elon Musk forms several ‘X Holdings’ companies to fund potential Twitter buyout

3 Mins Read

Thursday’s filing dispelled some doubts, though Musk still has work to do. He and his advisers will spend the coming days vetting potential investors for the equity portion of his offer, according to people familiar with the matter

KV Prasad Journo follow politics, process in Parliament and US Congress. Former Congressional APSA-Fulbright Fellow

Buy RIL, expect decent returns in next 2-3 years: Dipan Mehta

KV Prasad Jun 13, 2022, 06:35 AM IST (Published)

Listen to the Article (6 Minutes)

“I would go with Reliance Industries Ltd (RIL). I feel that from this point on, RIL may give decent returns over the longer-term,” said Dipan Mehta, Director at Elixir Equities in an interview with CNBC-TV18.

He believes that a marginal miss on earnings and some bit of over-expectation by the market is what led to a decline in RIL shares on Monday.

“Eventually the stock should recover lost ground over the next few trading sessions. I am not that pessimistic as far as RIL is concerned and I do expect that the stock will start performing well again. This is a deep correction and if you buy around these levels or so, you could expect decent returns over the next 2-3 years period,” he added.

According to Dipan, Hero MotoCorp is the best pick in the two-wheeler space. “I would go with Hero Motocorp at this point of time. Valuations are comfortable, return ratios are pretty much high, there is opportunity when it comes to export markets in some of the premium products, so that would be the best pick in the two-wheeler space,” he said.

Disclosure: Network18, the parent company of CNBCTV18.com, is controlled by Independent Media Trust, of which Reliance Industries is the sole beneficiary.

Disclaimer: The views and investment tips expressed by investment experts on CNBCTV18.com are their own and not that of the website or its management. CNBCTV18.com advises users to check with certified experts before taking any investment decisions.

For more, watch video…

Elon Musk forms several ‘X Holdings’ companies to fund potential Twitter buyout

3 Mins Read

Thursday’s filing dispelled some doubts, though Musk still has work to do. He and his advisers will spend the coming days vetting potential investors for the equity portion of his offer, according to people familiar with the matter

KV Prasad Journo follow politics, process in Parliament and US Congress. Former Congressional APSA-Fulbright Fellow

Positive on banks, NBFCs; safe to own HDFC Bank & Kotak: Dipan Mehta

KV Prasad Jun 13, 2022, 06:35 AM IST (Published)

Listen to the Article (6 Minutes)

HDFC Bank and Kotak Mahindra Bank are the safe stocks to own, said Dipan Mehta, Director at Elixir Equities in an interview with CNBC-TV18.

“They are secular growth stories and if you want safety with growth then HDFC Bank and Kotak Mahindra Bank are a must have in your portfolio,” he added.

According to him, reports of Kotak Mahindra Bank and IndusInd Bank deal were a complete rumour. “A few weeks ago, Hinduja Group said that they wanted to increase the stake in IndusInd Bank. So I don’t think that when you have such strong promoter in IndusInd Bank they would like to dilute their holdings and get merged with Kotak and to an extent lose their identity,” he said.

“One shouldn’t bet specifically on this event taking place. On the whole if you have slightly more risk appetite then IndusInd Bank may tend to outperform over the next six-twelve months the entire banking index,” he added.

Mehta is positive on the banking and non-banking financial companies (NBFCs) sector as a whole. He feels they may regain the leadership position in next year.

Dipan believes one needs to be a bit cautious on Reliance Industries Ltd (RIL). “No doubt, great company and certainly fantastic long-term prospects given the kind of efforts that have been done on setting up new businesses but you could have a soft patch in RIL and a fair bit of underperformance,” he said.

(Disclosures: Network18, the parent company of CNBCTV18.com, is controlled by Independent Media Trust, of which Reliance Industries is the sole beneficiary.)

Elon Musk forms several ‘X Holdings’ companies to fund potential Twitter buyout

3 Mins Read

Thursday’s filing dispelled some doubts, though Musk still has work to do. He and his advisers will spend the coming days vetting potential investors for the equity portion of his offer, according to people familiar with the matter

KV Prasad Journo follow politics, process in Parliament and US Congress. Former Congressional APSA-Fulbright Fellow

Here’s why Dipan Mehta prefers JK Cement, Birla Corp over frontline cement names

KV Prasad Jun 13, 2022, 06:35 AM IST (Published)

Listen to the Article (6 Minutes)

ACC numbers have been good and that is a precursor of what we can expect from the cement industry, said Dipan Mehta, Director, Elixir Equities in an interview with CNBC-TV18.

He expects ACC and other cement stocks to move in tandem with the market. With the overall economy opening up and rural consumption picking up, he hopes to see higher cement volumes.

“It is better to go for companies where we expect expansion plans to go onstream. Something like JK Cement, Birla Corporation may perhaps outperform the biggies like ACC, Ambuja Cement, UltraTech Cement and Shree Cement,” he said.

Among IT plays, he says L&T Tech is a good medium-long term investment.

Elon Musk forms several ‘X Holdings’ companies to fund potential Twitter buyout

3 Mins Read

Thursday’s filing dispelled some doubts, though Musk still has work to do. He and his advisers will spend the coming days vetting potential investors for the equity portion of his offer, according to people familiar with the matter

KV Prasad Journo follow politics, process in Parliament and US Congress. Former Congressional APSA-Fulbright Fellow

Here’s why Elixir’s Dipan Mehta likes metal stocks, including Vedanta

KV Prasad Jun 13, 2022, 06:35 AM IST (Published)

Listen to the Article (6 Minutes)

There is significant improvement in volumes across the board for commodity stocks, ferrous, non-ferrous and prices as well have gone back to pre-COVID levels, Dipan Mehta, Director at Elixir Equities said in an interview with CNBC-TV18. He is positive on the sector.

According to him, Vedanta is such a major player within the metals industry, and so will benefit from a cyclical upswing in the prices and volumes. These are high operating leverage business, so as and when revenues go up, profits will rise even sharply, he said. “I am quite positive on Vedanta,” Mehta said.

On consumer durables, Mehta said the best way to play rising consumer and changing demographics in India was through shares of consumer appliance companies. A lot of consumer appliances are now in higher demand than they were before, he said.

“There is a lot of choice as far as the consumer durable companies are concerned and investor should have a specific strategy as to which categories they want to be in and have a few holdings over there in their portfolio,” he said.

Elon Musk forms several ‘X Holdings’ companies to fund potential Twitter buyout

3 Mins Read

Thursday’s filing dispelled some doubts, though Musk still has work to do. He and his advisers will spend the coming days vetting potential investors for the equity portion of his offer, according to people familiar with the matter

KV Prasad Journo follow politics, process in Parliament and US Congress. Former Congressional APSA-Fulbright Fellow

Here’s what Dipan Mehta of Elixir Equities has to say about telecom, pharma stocks

KV Prasad Jun 13, 2022, 06:35 AM IST (Published)

Listen to the Article (6 Minutes)

Market expert Dipan Mehta of Elixir Equities in an interview with CNBC-TV18 shared his views on certain stocks/sectors.

When asked about telecom space, he said from an an investment perspective, they still prefer Bharti Airtel but think Vodafone-Idea could be a trading pick. “Vodafone-Idea still remains within the purview of traders and from an investment perspective one would still like to avoid it. The correction which has taken place in Bharti Airtel makes it a good solid long-term investment buy and investors can make it as a part of their core holdings.

With regards to IndusInd Bank, Mehta said, “It is really perplexing, we have seen the management come in and say that it is business as usual and they are sitting on lot of liquidity and as such there are no challenges for them- yet the stock keeps on sliding the way it has. This particular resolution for telecom is highly beneficial for IndusInd Bank which has a major exposure to Vodafone but still the stock seems to continuously correct. I think it is just a stock which was greatly in favour over the past decade or so and now it is finally getting out of favour and long term core holdings are getting sold off in IndusInd Bank.”

Talking about Aurobindo Pharma he said, “The usual disclosure is that we and our clients are invested in it. With the associated risk factors about USFDA inspection and all those action whether be it warning letter or import alert, all those are still dangling swords, some of it has got already priced in given that it is amongst the cheapest pharmaceutical stock in its peer group.”

According to him, what investors prefer in Aurobindo Pharma is large scale of backward integration, which means that they have a cost advantage and maybe the expectation that you would have in the next few weeks the approval for the Sandoz acquisition of their generic product, which could be a trigger for Aurobindo Pharma.

“On the whole investors are getting quite favourable and positive on the pharmaceutical industry especially those exporting to US. They will find the environment improve significantly post Coronavirus not only in terms of demand, but maybe hopefully also in terms of regulatory actions which the USFDA may take. So there is a hope that they may be a bit more lenient and quicker in terms of approving ANDA,” he added.

“So from that point of view, we are positive on the pharma industry and Aurobindo is certainly a stock we prefer to buy but it is more for investors who have a really longer term outlook,” said Mehta.

Elon Musk forms several ‘X Holdings’ companies to fund potential Twitter buyout

3 Mins Read

Thursday’s filing dispelled some doubts, though Musk still has work to do. He and his advisers will spend the coming days vetting potential investors for the equity portion of his offer, according to people familiar with the matter

KV Prasad Journo follow politics, process in Parliament and US Congress. Former Congressional APSA-Fulbright Fellow